Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
EVH

EVH - Evolent Health Inc Stock Price, Fair Value and News

$2.98-0.08 (-2.61%)
Delayed

71/100

EVH

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

71/100

EVH

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

EVH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EVH Price Action

Last 7 days

-6.0%

Last 30 days

11.6%

Last 90 days

-27.7%

Trailing 12 Months

-68.8%

EVH RSI Chart

EVH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EVH Valuation

Market Cap

332.7M

Price/Earnings (Trailing)

-0.62

Price/Sales (Trailing)

0.18

EV/EBITDA

-0.43

Price/Free Cashflow

8.56

EVH Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

EVH Fundamentals

EVH Revenue

Revenue (TTM)

1.9B

Rev. Growth (Yr)

-27.5%

Rev. Growth (Qtr)

-2.26%

EVH Earnings

Earnings (TTM)

-534.5M

Earnings Growth (Yr)

-1.8K%

Earnings Growth (Qtr)

-2.0K%

EVH Profitability

Operating Margin

21.31%

EBT Margin

-28.50%

Return on Equity

-128.74%

Return on Assets

-28.14%

Free Cashflow Yield

11.68%

EVH Investor Care

Buy Backs (1Y)

4.25%

Diluted EPS (TTM)

-5.15

EVH Alerts

  • Big fall in Revenue (Y/Y)
  • Big fall in earnings (Y/Y)
  • Losses in recent quarter

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20252.4B2.2B2.1B1.9B
20242.2B2.4B2.5B2.6B
20231.5B1.6B1.8B2.0B
2022989.9M1.1B1.2B1.4B
2021918.5M923.2M906.1M908.0M
2020869.9M895.2M914.6M924.6M
2019685.1M732.8M803.0M846.4M
2018468.4M505.7M547.7M627.1M
2017311.0M361.5M409.2M434.9M
2016146.3M192.4M212.2M254.2M
2015049.4M73.1M96.9M
201300025.7M
Get all data in R, Python etc through our Historical Stock Data APIs

About Evolent Health Inc

EVH
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology, cardiology, and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
 CEO
 WEBSITEevolenthealth.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES5100

Evolent Health Inc Frequently Asked Questions

EVH is the stock ticker symbol of Evolent Health Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of Evolent Health Inc is 332.68 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, EVH's PE ratio (Price to Earnings) is -0.62 and Price to Sales (PS) ratio is 0.18. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EVH PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Evolent Health Inc has provided -0.112 (multiply by 100 for percentage) rate of return.